Phase 2/3

NEW HAVEN, Conn. and SEOUL, South Korea, Aug. 26, 2026 Biohaven Ltd. and SK Biopharmaceuticals announced a strategic global...

Newton, Massachusetts, August 18, 2026 Abcuro, Inc. has announced the closing of a $66 million Series D financing to...

HOUSTON, July 6, 2026 Moleculin Biotech announced that Chairman and Chief Executive Officer Walter Klemp discussed encouraging preliminary results...

Boston, Massachusetts | April 24, 2026 Compass Therapeutics has announced it will present topline secondary endpoint data from its...